Follow the science, follow the Fauci
In medicine, the first objective is always: “Do no harm,” and for business, it’s: “Don’t throw good money after bad.”
Brand-new uncertainty
How will you compete in tomorrow’s reawakened economy?
“Title theft” myth persists, but mongers of “protection” against it have slightly improved their mislabeled product
Semanoff Ormsby Greenberg & Torchia, LLC’s William Maffucci continues his exploration of “title theft” and providers of “title lock” protection.
Why 2021 might be the year to sell your business
Huntington’s Jim Altman looks ahead at the 2021 M&A environment and why this year may (or may not) be a good year to sell a business.
EPA heightens aftermarket defeat device enforcement
Babst Calland’s Julie Domike and Gina Falaschi explore the crackdown on the use of aftermarket defeat devices.
If you thought the worst of the supply chain crisis was over, buckle up
Take steps immediately to lessen the escalating risks resulting from the fracturing global supply chain.
Tips for taking charge when you’re not physically present
Tips for taking charge when you’re not physically present
Uncertainty remains, but dealmakers find strategies for success
A sampling of outlooks from Pittsburgh dealmakers across the M&A spectrum, offering their perspectives on what happened and what’s to come in a year still colored by COVID-19.
Rick Malir delegates, defers and deals his way toward 100 City Barbeque restaurants
How City Barbeque plans on reaching its private-equity-backed goal of more than 100 restaurants and a national footprint.
Proposed changes under the Biden Administration
Brady Ware’s Matt McKinnon dives into tax law changes expected under the Biden Administration and how they will impact businesses and individuals.